Evolving Paradigms in Sepsis Management: A Narrative Review.

Area of Science:

• Critical Care Medicine
• Immunology
• Infectious Diseases

Background:

• Sepsis is a life-threatening organ dysfunction from infection, causing significant global mortality.
• Current treatments targeting hyperinflammation and immunosuppression have largely failed to improve sepsis outcomes.
• There is a critical need for novel therapeutic strategies for sepsis management.

Purpose of the Study:

• To review the development of sepsis therapeutic agents.
• To analyze clinical trial failures in targeting hyperinflammation and immunosuppression.
• To explore reasons for trial failures and outline current research directions.

Main Methods:

• Literature review of clinical trials for sepsis therapeutics.
• Analysis of strategies targeting hyperinflammation and immunosuppression.
• Examination of research bridging theoretical advancements and clinical application.

Main Results:

• Many clinical trials targeting hyperinflammation and immunosuppression in sepsis have failed.
• Reasons for failure include the complex, multifaceted nature of sepsis pathogenesis.
• Personalized medicine and phenotypic categorization show promise for future sepsis therapies.

Conclusions:

• Understanding sepsis pathogenesis is crucial for developing effective treatments.
• Targeted and individualized therapies are needed to improve sepsis patient outcomes.
• Future research should focus on precise treatment strategies for better sepsis management.